Chanqi Ye
Overview
Explore the profile of Chanqi Ye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruan J, Li Q, Jin Y, Yin J, Ye C, Cheng F, et al.
Mol Ther
. 2025 Feb;
PMID: 39943686
Intrahepatic cholangiocarcinoma (ICC) is known for its diverse cell types and resistance to standard treatments, highlighting the importance of understanding its tumor microenvironment (TME) for improved prognostic accuracy and therapeutic...
2.
Xu S, Wan M, Ye C, Chen R, Li Q, Zhang X, et al.
Carcinogenesis
. 2024 Aug;
45(10):721-734.
PMID: 39086220
Intrahepatic cholangiocarcinoma is a rare disease associated with a poor prognosis, primarily due to early recurrence and metastasis. An important feature of this condition is microvascular invasion (MVI). However, current...
3.
Xu S, Cao L, Chen R, Ye C, Li Q, Jiang Q, et al.
Oncologist
. 2024 Jun;
29(8):e1061-e1072.
PMID: 38842680
Background: Patients with intrahepatic cholangiocarcinoma (ICC) are prone to recurrence and poor survival. Targeted therapy related to isocitrate dehydrogenase (IDH) is an extremely important treatment. IDH1 and IDH2 mutations are...
4.
Bao X, Li Q, Chen D, Dai X, Liu C, Tian W, et al.
Cell Rep Med
. 2024 Feb;
5(2):101399.
PMID: 38307032
Colorectal cancer (CRC) is a common malignancy involving multiple cellular components. The CRC tumor microenvironment (TME) has been characterized well at single-cell resolution. However, a spatial interaction map of the...
5.
Dai X, Zhang J, Bao X, Guo Y, Jin Y, Yang C, et al.
Adv Mater
. 2023 May;
35(35):e2303542.
PMID: 37192546
The combination of ferroptosis inducers and immune checkpoint blockade can enhance antitumor effects. However, the efficacy in tumors with low immunogenicity requires further investigation. In this work, a water-in-oil Pickering...
6.
Shen Y, Xu S, Ye C, Li Q, Chen R, Wu W, et al.
iScience
. 2023 Feb;
26(2):106003.
PMID: 36852159
Despite the epidemiological association between intrahepatic cholangiocarcinoma (ICC) and hepatitis B virus (HBV) infection, little is known about the relevant oncogenic effects. A cohort of 32 HBV-infected ICC and 89...
7.
Ruan J, Xu S, Chen R, Qu W, Li Q, Ye C, et al.
Brief Bioinform
. 2022 Oct;
23(6).
PMID: 36259363
Robust strategies to identify patients at high risk for tumor metastasis, such as those frequently observed in intrahepatic cholangiocarcinoma (ICC), remain limited. While gene/protein expression profiling holds great potential as...
8.
Jiang Q, Xie M, Chen R, Yan F, Ye C, Li Q, et al.
Front Immunol
. 2022 Sep;
13:973601.
PMID: 36105816
Background: As the forefront of nanomedicine, bionic nanotechnology has been widely used for drug delivery in order to obtain better efficacy but less toxicity for cancer treatments. With the rise...
9.
Chen R, Zheng D, Li Q, Xu S, Ye C, Jiang Q, et al.
Cancer Lett
. 2022 Aug;
546:215853.
PMID: 35921970
Cholangiocarcinoma (CCA) is a group of malignant heterogeneous cancer arising from the biliary tree. CCA has become a global health problem with rising incidence and mortality that threatens the health...
10.
Xu S, Ye C, Chen R, Li Q, Ruan J
Cancers (Basel)
. 2022 Jun;
14(12).
PMID: 35740577
Gastroenteropancreatic neuroendocrine neoplasms feature high heterogeneity. Neuroendocrine tumor cells are closely associated with the tumor microenvironment. Tumor-infiltrating immune cells are mutually educated by each other and by tumor cells. Immune...